AdriannSax photoCEO, Vetigenics

Adriann is CEO of Vetigenics. Previously, Adriann was an Entrepreneur in Residence at Fortress Biotech, a public biotech company which finds and forms subsidiary companies around promising drugs and technologies. For more than 25 years, Adriann has been a global biotech and pharmaceutical industry leader managing all stages of drug development, commercialization, strategic deal-making and partnerships. Prior to Fortress Biotech, Adriann was Executive Vice President, Chief Commercial Officer of Kadmon Corporation leading Kadmon’ s commercial organization, Kadmon Pharmaceuticals, from its inception in September 2010.

Before Kadmon, Adriann was Executive Vice President, Business Development and Strategic Planning at King Pharmaceuticals where she led many profitable transactions in addition to creating and implementing King’s Corporate Strategy for Growth in 2005, contributing to the company’s overall success and ultimate sale to Pfizer in 2011.

After starting her career as a sales representative at Sterling Drug, Adriann progressed through a series of management and executive roles with established biopharmaceutical companies including Symphogen, Merck, BMS and Roche in commercial operations, strategy and corporate development. Although she’s made many important contributions in the areas of oncology, transplantation and hepatology, her leadership of many successful new product launches including leading the team responsible for the refiling and ultimate launch of ERBITUX® (cetuximab), for the treatment of cancer are testimony to her unique abilities, commitment and tenacity to “make a difference”.

Throughout her professional career, Adriann has maintained an active role with the many industry associations. In 2008, she was voted as one of the top 100 Most Inspiring People in Healthcare by PharmaVoice Magazine, in 2016 to the Business Advisory Board of Cures Within Reach and in 2014 as a member of the Springboard Life Sciences Council Executive Board. She is also a board member, strategic advisor and mentor to many start-up biotech companies. Adriann holds an MBA in Marketing and Finance from the Keller Graduate School of Management and a BS in Pre-Veterinary Medicine from the University of Delaware.


Click here to sign up for our eNewsletter today!

Please include your Full Name* and Email Address*


If the link above doesn't work, please contact our Admin support at with your Full Name and Email Address to sign up!


Cures Within Reach

134 N. LaSalle, #1130
Chicago, IL 60602

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes. 

Partnership for Cures DBA Cures Within Reach is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Sunday the 9th. Copyright 2018 Cures Within Reach.